Related Experiment Video
Updated: Jan 27, 2026
15:00
A Tablet-Based Curriculum-Based Measurement Protocol for Kindergarten Writing
Published on: February 7, 2025
1.1K
Evolution to a Competency-Based Training Curriculum for Pharmaceutical Medicine Physicians in Switzerland
Gabriel Schnetzler1, Markus F Bremgartner2,3, Regina Grossmann Straessle4
1F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Frontiers in Pharmacology
|March 16, 2019
Summary
Pharmaceutical Medicine in Switzerland is a recognized specialty focused on patient benefit through drug development and use. Training is being revised to create a Swiss Catalog of Core Competencies (SC³-PM) for broader healthcare roles.
Area of Science:
- Medical Science
- Pharmaceutical Sciences
- Healthcare Education
Background:
- Pharmaceutical Medicine is an established medical specialty in Switzerland.
- Its core aim is to ensure optimal therapeutic coverage via evidence-based drug development and utilization.
- Specialists collaborate across the healthcare system throughout the drug lifecycle.
Purpose of the Study:
- To revise the postgraduate training curriculum for Pharmaceutical Medicine in Switzerland.
- To develop a Swiss Catalog of Core Competencies in Pharmaceutical Medicine (SC³-PM).
- To adapt the IFAPP competency framework for academic and regulatory roles.
Main Methods:
- Review and adaptation of the IFAPP competency framework.
- Development of the Swiss Catalog of Core Competencies in Pharmaceutical Medicine (SC³-PM).
- Alignment with Swiss postgraduate training requirements.
Main Results:
- A revised training framework is under development.
- The SC³-PM aims to encompass competencies for diverse roles within Pharmaceutical Medicine.
- The adapted framework will better suit academic and regulatory settings.
Conclusions:
- The ongoing revision of Pharmaceutical Medicine training in Switzerland is crucial.
- The SC³-PM will enhance competency-based education and professional standards.
- Adapting international frameworks ensures relevance for national healthcare needs.
Related Concept Videos
02:55The Evidence for Evolution
47.9K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
47.9K
01:54Convergent Evolution
32.7K
Evolution shapes the features of organisms over time, ensuring that they are suited for the environments in which they live. Sometimes, selection pressure leads to the rise of similar but unrelated adaptations in organisms with no recent common ancestors, a process known as convergent evolution.
32.7K
01:26Pharmaceutical Equivalents
201
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
201
01:24Eukaryotic Evolution
40.7K
The endosymbiont theory is the most widely accepted theory of eukaryotic evolution; however, its progression is still somewhat debated. According to the nucleus-first hypothesis, the ancestral prokaryote first evolved a membrane to enclose DNA and form the nucleus. Conversely, the mitochondria-first hypothesis suggests that the nucleus was formed after endosymbiosis of mitochondria.
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
40.7K
02:31Synteny and Evolution
3.8K
John H. Renwick first coined the term “synteny” in 1971, which refers to the genes present on the same chromosomes, even if they are not genetically linked. The species with common ancestry tend to show conserved syntenic regions. Therefore, the concept of synteny is nowadays used to describe the evolutionary relationship between species.
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...
3.8K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
191
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
191